Introduction: Risk factors for developing pancreatitis due to thiopurines in patients with inflammatory bowel disease (IBD) are not clearly identified. Our aim was to evaluate the predictive pharmacogenetic risk of pancreatitis in IBD patients treated with thiopurines. Methods: We conducted an observational pharmacogenetic study of acute pancreatitis events in a cohort study of IBD patients treated with thiopurines from the prospectively maintained ENEIDA registry biobank of GETECCU. Samples were obtained and the CASR, CEL, CFTR, CDLN2, CTRC, SPINK1, CPA1, and PRSS1 genes, selected based on their known association with pancreatitis, were fully sequenced. Results: Ninety-five cases and 105 controls were enrolled; a total of 57% were women. Median age at pancreatitis diagnosis was 39 years. We identified 81 benign variants (50 in cases and 67 in controls) and a total of 35 distinct rare pathogenic and unknown significance variants (10 in CEL, 21 in CFTR, 1 in CDLN2, and 3 in CPA1). None of the cases or controls carried pancreatitis-predisposing variants within the CASR, CPA1, PRSS1, and SPINK1 genes, nor a pathogenic CFTR mutation. Four different variants of unknown significance were detected in the CDLN and CPA1 genes; one of them was in the CDLN gene in a single patient with pancreatitis and 3 in the CPA1 gene in 5 controls. After the analysis of the variants detected, no significant differences were observed between cases and controls. Conclusion: In patients with IBD, genes known to cause pancreatitis seem not to be involved in thiopurine-related pancreatitis onset.

1.
Bermejo
F
,
Aguas
M
,
Chaparro
M
,
Domènech
E
,
Echarri
A
,
García-Planella
E
, et al
.
Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis(GETECCU) on the use of thiopurines in inflammatory bowel disease
.
Gastroenterol Hepatol
.
2018
;
41
(
3
):
205
21
.
2.
Chaparro
M
,
Ordás
I
,
Cabré
E
,
Garcia-Sanchez
V
,
Bastida
G
,
Peñalva
M
, et al
.
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients
.
Inflamm Bowel Dis
.
2013
;
19
(
7
):
1404
10
.
3.
Gordon
M
,
Grafton-Clarke
C
,
Akobeng
A
,
Macdonald
J
,
Chande
N
,
Hanauer
S
, et al
.
Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
.
Frontline Gastroenterol
.
2021
;
12
(
5
):
423
36
.
4.
Weersma
RK
,
Peters
FTM
,
Oostenbrug
LE
,
Van Den Berg
AP
,
Van Haastert
M
,
Ploeg
RJ
, et al
.
Increased incidence of azathioprine-induced pancreatitis in Crohn’s disease compared with other diseases
.
Aliment Pharmacol Ther
.
2004
;
20
(
8
):
843
50
.
5.
Teich
N
,
Mohl
W
,
Bokemeyer
B
,
Bündgens
B
,
Büning
J
,
Miehlke
S
, et al
.
Azathioprine-induced acute pancreatitis in patients with inflammatory bowel diseases: A prospective study on incidence and severity
.
J Crohns Colitis
.
2016
;
10
(
1
):
61
8
.
6.
Eskazan
T
,
Bozcan
S
,
Atay
K
,
Yildirim
S
,
Demir
N
,
Celik
S
, et al
.
Frequency, predisposing factors, and clinical outcome of azathioprine-induced pancreatitis among patients with inflammatory bowel disease: results from a tertiary referral center
.
Pancreas
.
2021
;
50
(
9
):
1274
80
.
7.
Freitas
M
,
Lima Capela
T
,
Macedo Silva
V
,
Arieira
C
,
Cúrdia Gonçalves
T
,
Dias De Castro
F
, et al
.
Finding predictors of azathioprine-induced pancreatitis in patients with inflammatory bowel disease
.
Pancreas
.
2022
;
51
(
3
):
288
94
.
8.
Heap
GA
,
Weedon
MN
,
Bewshea
CM
,
Singh
A
,
Chen
M
,
Satchwell
JB
, et al
.
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants
.
Nat Genet
.
2014
;
46
(
10
):
1131
4
.
9.
Whitcomb
DC
,
Gorry
MC
,
Preston
RA
,
Furey
W
,
Sossenheimer
MJ
,
Ulrich
CD
, et al
.
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
.
Nat Genet
.
1996
;
14
(
2
):
141
5
.
10.
Whitcomb
DC
.
Mechanisms of disease: advances in understanding the mechanisms leading to chronic pancreatitis
.
Nat Clin Pract Gastroenterol Hepatol
.
2004
;
1
(
1
):
46
52
.
11.
Howes
N
,
Lerch
MM
,
Greenhalf
W
,
Stocken
DD
,
Ellis
I
,
Simon
P
, et al
.
Clinical and genetic characteristics of hereditary pancreatitis in Europe
.
Clin Gastroenterol Hepatol
.
2004
;
2
(
3
):
252
61
.
12.
Whitcomb
DC
.
Genetic risk factors for pancreatic disorders
.
Gastroenterology
.
2013
;
144
(
6
):
1292
302
.
13.
Zabana
Y
,
Panés
J
,
Nos
P
,
Gomollón
F
,
Esteve
M
,
García-Sánchez
V
, et al
.
The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: design, monitoring and functions
.
Gastroenterol Hepatol
.
2020
;
43
(
9
):
551
8
.
14.
Banks
PA
,
Bollen
TL
,
Dervenis
C
,
Gooszen
HG
,
Johnson
CD
,
Sarr
MG
, et al
.
Classification of acute pancreatitis: 2012: revision of the Atlanta classification and definitions by international consensus
.
Gut
.
2013
;
62
(
1
):
102
11
.
15.
Anand
S
,
Mangano
E
,
Barizzone
N
,
Bordoni
R
,
Sorosina
M
,
Clarelli
F
, et al
.
Next generation sequencing of pooled samples: guideline for variants’ filtering
.
Sci Rep
.
2016
;
6
:
33735
.
16.
Richards
S
,
Aziz
N
,
Bale
S
,
Bick
D
,
Das
S
,
Gastier-Foster
J
, et al
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology
.
Genet Med
.
2015
;
17
(
5
):
405
24
.
17.
Angyal
D
,
Bijvelds
MJC
,
Bruno
MJ
,
Peppelenbosch
MP
,
de Jonge
HR
.
Bicarbonate transport in cystic fibrosis and pancreatitis
.
Cells
.
2021
;
11
(
1
):
54
.
18.
Mayerle
J
,
Sendler
M
,
Hegyi
E
,
Beyer
G
,
Lerch
MM
,
Sahin-Tóth
M
.
Genetics, cell biology, and pathophysiology of pancreatitis
.
Gastroenterology
.
2019
;
156
(
7
):
1951
68.e1
.
19.
Whitcomb
DC
.
Genetic aspects of pancreatitis
.
Annu Rev Med
.
2010
;
61
:
413
24
.
20.
Park
HW
,
Nam
JH
,
Kim
JY
,
Namkung
W
,
Yoon
JS
,
Lee
JS
, et al
.
Dynamic regulation of CFTR bicarbonate permeability by [Cl-]i and its role in pancreatic bicarbonate secretion
.
Gastroenterology
.
2010
;
139
(
2
):
620
31
.
21.
Miller
AC
,
Comellas
AP
,
Hornick
DB
,
Stoltz
DA
,
Cavanaugh
JE
,
Gerke
AK
, et al
.
Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions
.
Proc Natl Acad Sci U S A
.
2020
;
117
(
3
):
1621
7
.
22.
Fisman
D
.
Cystic fibrosis heterozygosity: carrier state or haploinsufficiency
.
Proc Natl Acad Sci U S A
.
2020
;
117
(
6
):
2740
2
.
23.
Ooi
CY
,
Dorfman
R
,
Cipolli
M
,
Gonska
T
,
Castellani
C
,
Keenan
K
, et al
.
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis
.
Gastroenterology
.
2011
;
140
(
1
):
153
61
.
24.
Gravdal
A
,
Xiao
X
,
Cnop
M
,
El JellasJohanssonNjølstad
KSPR
,
Lowe
ME
,
Johansson
BB
, et al
.
The position of single-base deletions in the VNTR sequence of the Carboxyl Ester Lipase (CEL) gene determines proteotoxicity
.
J Biol Chem
.
2021
;
296
:
100661
.
25.
El Jellas
K
,
Dušátková
P
,
Haldorsen
IS
,
Molnes
J
,
Tjora
E
,
Johansson
BB
, et al
.
Two new mutations in the CEL gene causing diabetes and hereditary pancreatitis: how to correctly identify MODY8 cases
.
J Clin Endocrinol Metab
.
2022
;
107
(
4
):
E1455
66
.
26.
Floyd
A
,
Pedersen
L
,
Nielsen
GL
,
Thorlacius-Ussing
O
,
Sorensen
HT
.
Risk of acute pancreatitis in users of azathioprine: a population-based case-control study
.
Am J Gastroenterol
.
2003
;
98
(
6
):
1305
8
.
27.
Bermejo
F
,
Lopez-Sanroman
A
,
Taxonera
C
,
Gisbert
JP
,
Pérez-Calle
JL
,
Vera
I
, et al
.
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis
.
Aliment Pharmacol Ther
.
2008
;
28
(
5
):
623
8
.
28.
Simone
PD
,
Pavlov
YI
,
Borgstahl
GEO
.
ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics
.
Mutat Res
.
2013
;
753
(
2
):
131
46
.
29.
Ribaldone
DG
,
Adriani
A
,
Caviglia
GP
,
NicolòAgnesod
AD
,
Simiele
M
,
Riganò
D
, et al
.
Correlation between thiopurine S-methyltransferase genotype and adverse events in inflammatory bowel disease patients
.
Medicina
.
2019
;
55
(
8
):
441
.
30.
Dubois
PCA
.
The risk of azathioprine-induced pancreatitis depends on genetic variants in the HLA gene region
.
Gut
.
2011
;
60
(
Suppl 1
):
A60
. A60 LP-A60.
31.
Wilson
A
,
Wang
Q
,
Choi
YH
,
Ponich
T
,
Gregor
JC
,
Chande
N
, et al
.
Pretreatment HLADQA1-HLADRB1 testing for the prevention of azathioprine-induced pancreatitis in inflammatory bowel disease: a prospective cohort study
.
Clin Transl Gastroenterol
.
2021
;
12
(
4
):
E00332
.
32.
Teich
N
,
Bruns
T
,
Stallmach
A
.
Letter: predicting azathioprine-associated pancreatitis in IBD-phenotype or genotype
.
Aliment Pharmacol Ther
.
2018
;
47
(
7
):
1042
3
.
You do not currently have access to this content.